Provided by Tiger Trade Technology Pte. Ltd.

IGC Pharma

0.3080
+0.030811.11%
Post-market: 0.3001-0.0079-2.56%19:50 EDT
Volume:1.87M
Turnover:553.46K
Market Cap:31.84M
PE:-3.95
High:0.3100
Open:0.2875
Low:0.2787
Close:0.2772
52wk High:0.4985
52wk Low:0.2350
Shares:103.38M
Float Shares:90.33M
Volume Ratio:1.95
T/O Rate:2.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0780
EPS(LYR):-0.0931
ROE:-83.34%
ROA:-50.31%
PB:3.94
PE(LYR):-3.31

Loading ...

Aug 19, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2020

Major Issues Report

8-K - Current report
Jul 20, 2020

Major Issues Report

8-K - Current report
Jul 13, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 13, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Major Issues Report

8-K - Current report
Mar 27, 2020

Major Issues Report

8-K - Current report
Mar 16, 2020

Major Issues Report

8-K - Current report
Feb 25, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 10, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jan 09, 2020

Major Issues Report

Current report, item 5.07
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 14, 2019

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Mar 27, 2019

Major Issues Report

Current report, items 8.01 and 9.01